| scholarly article | Q13442814 |
| P356 | DOI | 10.1042/0264-6021:3500207 |
| P8608 | Fatcat ID | release_dqxifixqsnf2xj43ffp56p7gia |
| P932 | PMC publication ID | 1221243 |
| P698 | PubMed publication ID | 10926845 |
| P5875 | ResearchGate publication ID | 12393320 |
| P2093 | author name string | Häussinger D | |
| Block C | |||
| Graf D | |||
| Schliess F | |||
| Kurz AK | |||
| Dahl SV | |||
| P2860 | cites work | The 2.2 A crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue | Q24323252 |
| A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 | ||
| Proteins regulating Ras and its relatives | Q28257295 | ||
| A synthetic inhibitor of the mitogen-activated protein kinase cascade | Q28367955 | ||
| PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo | Q28609356 | ||
| cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor | Q28775865 | ||
| The mitogen-activated protein kinase signal transduction pathway | Q29620226 | ||
| Mitogen-activated protein kinases: specific messages from ubiquitous messengers | Q30303652 | ||
| Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase | Q30450248 | ||
| Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis | Q33910573 | ||
| Involvement of microtubules in the link between cell volume and pH of acidic cellular compartments in rat and human hepatocytes | Q35767601 | ||
| Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase | Q38298684 | ||
| Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children | Q40457634 | ||
| Hepatoprotection by hydrophilic bile salts | Q40649152 | ||
| Ursodiol for hepatobiliary disorders | Q40664612 | ||
| Molecular mechanisms of hepatic bile salt transport from sinusoidal blood into bile | Q40952050 | ||
| Mitogen and stress response pathways: MAP kinase cascades and phosphatase regulation in mammals and yeast | Q40974442 | ||
| LY294002-mediated inhibition of phosphatidylinositol 3-kinase activity triggers growth inhibition and apoptosis in CD40-triggered Ramos-Burkitt lymphoma B cells | Q41010076 | ||
| Minimal Ras-binding domain of Raf1 can be used as an activation-specific probe for Ras. | Q41128325 | ||
| Role of anion translocation across the mitochondrial membrane in the regulation of urea synthesis from ammonia by isolated rat hepatocytes | Q41790808 | ||
| Cell volume and bile acid excretion | Q41836065 | ||
| Activation of extracellular signal-regulated kinases Erk-1 and Erk-2 by cell swelling in H4IIE hepatoma cells | Q42021777 | ||
| Mechanism of inhibition of Raf-1 by protein kinase A. | Q42030118 | ||
| Cell swelling increases bile flow and taurocholate excretion into bile in isolated perfused rat liver | Q42123790 | ||
| Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes | Q42454944 | ||
| Effects of tauroursodeoxycholic acid on cytosolic Ca2+ signals in isolated rat hepatocytes | Q42509692 | ||
| Regulation of taurocholate excretion by a hypo-osmolarity-activated signal transduction pathway in rat liver. | Q42516280 | ||
| Selective inhibition of protein kinase C isozymes by the indolocarbazole Gö 6976. | Q42558480 | ||
| Involvement of microtubules in the swelling-induced stimulation of transcellular taurocholate transport in perfused rat liver | Q42797129 | ||
| Adenovirus-mediated gene transfer of dominant negative ras(asn17) in 3T3L1 adipocytes does not alter insulin-stimulated P13-kinase activity or glucose transport | Q42805771 | ||
| Cell cycle-dependent activation of Ras. | Q42806454 | ||
| The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival | Q42828483 | ||
| The use of perfusion of liver and other organs for the study of microsomal electron-transport and cytochrome P-450 systems | Q43832144 | ||
| Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes | Q44946866 | ||
| Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. | Q44951192 | ||
| Bioavailability, gastrointestinal transit, solubilization and faecal excretion of ursodeoxycholic acid in man. | Q45104953 | ||
| Tauroursodeoxycholate and tauro-beta-muricholate exert cytoprotection by reducing intrahepatocyte taurochenodeoxycholate content. | Q50784679 | ||
| Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity. | Q51560255 | ||
| Substrate-assisted catalysis as a mechanism for GTP hydrolysis of p21ras and other GTP-binding proteins. | Q52538724 | ||
| Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor | Q58197226 | ||
| Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: A study in isolated rat hepatocyte couplets | Q61952468 | ||
| Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial | Q68019501 | ||
| Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial | Q69357047 | ||
| Tauroursodeoxycholate prevents taurocholate induced cholestasis | Q70316364 | ||
| Molecular aspects of membrane stabilization by ursodeoxycholate [see comment] | Q70457384 | ||
| Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo | Q71011188 | ||
| Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes | Q71035961 | ||
| Inhibitory actions of cyclic adenosine monophosphate and pertussis toxin define two distinct epidermal growth factor-regulated pathways leading to activation of mitogen-activated protein kinase in rat hepatocytes | Q71057946 | ||
| Ursodeoxycholic acid in the treatment of primary biliary cirrhosis | Q72401649 | ||
| Parallel decrease of Na(+)-taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes | Q72567629 | ||
| Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver | Q73760652 | ||
| Osmodependent dynamic localization of the multidrug resistance protein 2 in the rat hepatocyte canalicular membrane | Q73835478 | ||
| Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes | Q77190586 | ||
| The role of phosphoinositide 3-kinase in taurocholate-induced trafficking of ATP-dependent canalicular transporters in rat liver | Q77359791 | ||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 207-213 | |
| P577 | publication date | 2000-08-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver | |
| P478 | volume | 350 Pt 1 |
| Q46422164 | A nuclear receptor ligand down-regulates cytosolic phospholipase A2 expression to reduce bile acid-induced cyclooxygenase 2 activity in cholangiocytes: implications of anticarcinogenic action of farnesoid X receptor agonists |
| Q36506491 | Bile acid interactions with cholangiocytes |
| Q33881922 | Bile formation and secretion |
| Q44569551 | Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation |
| Q34687676 | Drug therapy of primary biliary diseases: classical and modern strategies. |
| Q37341910 | Dynamic localization of hepatocellular transporters in health and disease. |
| Q34482125 | ERK1/2 and p38 MAPKs are complementarily involved in estradiol 17ß-D-glucuronide-induced cholestasis: crosstalk with cPKC and PI3K. |
| Q34448448 | INTRACELLULAR SIGNALING BY BILE ACIDS. |
| Q44429825 | Involvement of integrins and Src in tauroursodeoxycholate-induced and swelling-induced choleresis |
| Q45971853 | Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis. |
| Q42129552 | Osmotic regulation of insulin-induced mitogen-activated protein kinase phosphatase (MKP-1) expression in H4IIE rat hepatoma cells |
| Q41034426 | Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate |
| Q44355362 | Taurolithocholic acid exerts cholestatic effects via phosphatidylinositol 3-kinase-dependent mechanisms in perfused rat livers and rat hepatocyte couplets |
| Q35098259 | The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure |
| Q37919924 | Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. |
Search more.